Leo Petrossian, Chief Executive Officer
Leo Petrossian is the current Chief Executive Officer of Neurolutions, Inc.. He is an experienced nanotechnologist searching for challenging opportunities in biotechnology and medical device entre- and intra-preneurship. Previously he co-founded Neural Analytics and is also the CEO of Nile AI, Inc.
Dr. Petrossian earned his MBA from the UCLA Anderson School of Management in 2014 and earned his PhD & MS in Biomolecular Nanotechnology & Solid-State Device Physics as an NSF IGERT fellow at Arizona State University in 2007. He also holds a double B.S. in Electrical Engineering & Biomedical Engineering from California State University, Long Beach.
Kern Bhugra, Chief Operating Officer
Kern has over 20 years of experience in executive management and technology development in the medical device space. His career began
at IBM with responsibilities ranging from medical imaging to global technology operations in the US, Europe, and Asia. Kern co-founded Tibion Corporation, a leader in neuro-rehabilitation, in 2002 and drove Tibion from concept through commercialization and acquisition after serving as CEO/Chairman for 7 yrs. Following Tibion, Kern ran JunoPacific Inc., a medical device design, development, and manufacturing firm, where he grew the company to over 350 employees through acquisitions and organic expansion over his five-year tenure. After JunoPacific, Kern became the founding CEO at Neurolutions, where he built the team and
led the company through technology design, research & development, clinical studies, and managing the regulatory pathway to market entry.
He is also an inventor on several Neurolutions device technology patents.
In addition to Neurolutions, Kern served on the boards of Aerin Medical, Leonis Medical, an educational non-profit institution, as well as on the medical device screening committee of a Bay Area angel group. Kern has been a speaker at numerous conferences and academic institutions in the US, Europe, and Asia as well as a guest lecturer at Oxford University, Stanford University, and UC Berkeley. He holds several patents in the area of robotics-based neuro-rehabilitation. Kern received a BSEE from the University of Michigan and an MSEE with emphasis in bioengineering from Stanford University.
Eric Leuthardt, Co-founder and Chief Scientific Officer
Eric C. Leuthardt, M.D. is a neurosurgeon who is currently a professor in the Departments of Neurological Surgery, Neuroscience, Biomedical Engineering, Mechanical Engineering and Material Sciences at Washington University in St. Louis. He is also Chief of the Division of Neurotechnology. Leuthardt is an internationally renowned neurosurgeon and scientist.
His research has focused on thought-controlled devices linked to the brain that may restore function to patients with various types of disabilities.
His work in the field of neuroprosthetics, neurotechnologies, advanced brain imaging, and neurosurgical devices has yielded him numerous accolades as a pioneer in applied neuroscience. In addition to numerous peer-reviewed publications, Leuthardt has over 1600 patents on file with the U.S. Patent and Trademark Office for a myriad of medical devices and brain computer interface technologies. He is also the founder of eight startup companies, an Emmy Award winning playwright, and the author of two fiction novels, Red Devil 4 and Limbo.
Dan Moran, Co-founder
Daniel Moran received his undergraduate degree in Biomedical Engineering from the Milwaukee School of Engineering and his Ph.D. degree in Bioengineering from Arizona State University. Given his interest in neural engineering, Dr. Moran performed a postdoctoral fellowship in Systems Neurophysiology at the Neurosciences Institute in San Diego. Currently, Dr. Moran is a Professor in Biomedical Engineering at Washington University with joint appointments in Neurosurgery, Neuroscience and Physical Therapy.
Dr. Moran’s primary research interest is in the area of voluntary motor control. His lab investigates how various neural substrates control arm movements. Furthermore, Dr. Moran’s lab applies these scientific results to the development of novel neuroprosthetics devices. Current research projects involve controlling complex 3D musculoskeletal arm models with cortical signals and developing novel peripheral nerve interfaces for muscle control and haptic feedback. The goal of this research is to restore voluntary arm control in paralyzed individuals via motor cortical recordings and function electrical stimulation of arm muscles or prosthetic limbs.
Lauren Souders, Clinical Manager
Lauren Souders is the current Clinical Manager for Neurolutions, Inc., and has been working with Neurolutions since 2012 assisting in the development and clinical evolution applying brain-computer interface in the stroke rehabilitation space. Lauren was an integral clinical lead at the infancy of Neurolutions first product, the IpsiHand. Lauren is also one of the first pioneering occupational therapists to assist in using brain-computer interface technology with stroke patients.
Lauren has held other clinical roles as an occupational therapist with advanced certifications as a certified brain injury specialist (CBIS) and a certified stroke rehabilitation specialist (CSRS). Lauren also served as an adjunct faculty member at Saint Louis University and a clinical specialist for Washington University’s School of Medicine’s Department of Neurology. Lauren has presented at a number of conferences for the American Occupational Therapy Association and the American Congress of Rehabilitation Medicine. Lauren continues to serve as a guest lecturer at a number of universities including Saint Louis University and Maryville University. Lauren is a founding member of two other start-up companies. Overall, Lauren aspires to innovate creative medical technologies to provide solutions to improve the lives of those who need it the most.
Lauren Sheehan, Product Manager
Lauren Sheehan is the current Clinical Product Manager with Neurolutions, Inc. and has been in industry roles for the last four years. Lauren has held clinical roles in outpatient neuro-rehabilitation for over a decade as well as administrative roles in clinic management. She is a founding member of the American Congress of Rehab Medicine's Clinical Managers Task Force, supporting clinicians in industry roles in rehab-ilitation medicine. Lauren also serves as the Productive Aging Special Interest Section Technology Coordinator for the American Occupational Therapy Association. Lauren is an Adjunct Faculty Member at Samuel Merritt University in Oakland, CA. Lauren is also the co-founder of the Rehab Tech Summit, an online conference and community that aims to bring together industry professionals and rehabilitation clinicians, researchers and entrepreneurs to share information and ideas in the rehabilitation technology space.
Tim Proulx, Director of Engineering
Tim Proulx is the current Director of Engineering at Neurolutions, Inc. Tim has an extensive background in biomedical and electrical engineering and has held engineering management positions in the medical device space.
Tim was most recently recently the Vice President of Engineering at Zonare Medical Systems (Mindray North America) and Sonitus Medical.